Noxopharm Limited (ASX:NOX)

Noxopharm Revenue

Noxopharm had revenue of 1.73M AUD in the half year ending December 31, 2025, with 42.82% growth. This brings the company's revenue in the last twelve months to 3.40M, up 44.83% year-over-year. In the fiscal year ending June 30, 2025, Noxopharm had annual revenue of 2.82M with 17.52% growth.

• Revenue (ttm): 3.40M
• Revenue Growth: +44.83%
• P/S Ratio: 5.34
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 18.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	2.82M	420.56K	17.52%
Jun 30, 2024	2.40M	-3.61M	-60.06%
Jun 30, 2023	6.01M	581.44K	10.71%
Jun 30, 2022	5.43M	-179.61K	-3.20%
Jun 30, 2021	5.61M	-2.67M	-32.29%